Yasuyuki Seno

Treatment with the SGLT2 inhibitor luseogliflozin improves nonalcoholic steatohepatitis in a rodent model with diabetes mellitus

Shirong Qiang, Yusuke Nakatsu, Yasuyuki Seno et al. · Diabetology & Metabolic Syndrome · 2015 · 113 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model

Yusuke Nakatsu, Yasuyuki Seno, Akifumi Kushiyama et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 2015 · 86 citations

Life Sciences, Biochemistry, Pharmacology +16

Pin1 Inhibitor Juglone Exerts Anti-Oncogenic Effects on LNCaP and DU145 Cells despite the Patterns of Gene Regulation by Pin1 Differing between These Cell Lines

Ryuhei Kanaoka, Akifumi Kushiyama, Yasuyuki Seno et al. · PLoS ONE · 2015 · 24 citations · Full text

Medicine, Molecular Biology, Oncology +14

Prognostic significance of C-reactive protein in patients with intermediate-risk metastatic renal cell carcinoma treated with molecular targeted therapy

Jun Teishima, Kohei Kobatake, Tetsutaro Hayashi et al. · Oncology Letters · 2014 · 24 citations · Full text

Medicine, Oncology, Cancer Immunology +16

Retroperitoneoscopic treatment of ureteral invagination caused by a long fibroepithelial polyp protruding into the bladder: Report of a case

Yasuhisa Hasegawa, Koji Mita, Tetsuhiro Ueki et al. · Surgery Today · 2011 · 11 citations

Medicine, Surgery, Urology +9